Offering reliable and timely data, this report is a key resource for anyone building or refining their automated cell counter industry roadmap.
What Is The Expected CAGR For The Automated Cell Counter Market Through 2025?
The automated cell counter market size has grown strongly in recent years. It will grow from $5.42 billion in 2024 to $5.75 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increased awareness, advancements in diagnostic techniques, environmental factors, antifungal resistance, population growth, and immune compromised populations.
The automated cell counter market size is expected to see strong growth in the next few years. It will grow to $7.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to regulatory support, environmental concerns, antimicrobial resistance, an aging population, precision medicine, global healthcare spending, infectious disease outbreaks, research funding, accessibility, and affordability. Major trends in the forecast period include regulatory support for innovation, expansion of the biopharmaceutical sector, increasing research activities, global healthcare infrastructure development, a shift towards remote monitoring, and a and a rise in point-of-care testing.
Get your free sample today:
Which Key Factors Will Influence Automated Cell Counter Market Growth Over 2025-2034?
The rising adoption of personalized medicine is expected to propel the growth of the automated cell counter market going forward. Personalized medicine refers to tailoring medical treatment to each patient's individual characteristics, often based on genetic, environmental, and lifestyle factors. Personalized medicine applications are rising due to advancements in genetic research and technology, enabling more precise and effective treatments tailored to individual patient's unique genetic profiles and health data. Automated cell counting is utilized in personalized medicine to analyze patient-specific cell populations rapidly and accurately, aiding in the customization of treatments based on individual cellular profiles. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based hospital and healthcare company, the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from the 6 approved in 2022. Therefore, the rising adoption of personalized medicine will drive the growth of the automated cell counter market.
Comprehensive Segment-Wise Insights Into The Automated Cell Counter Market
The automated cell counter market covered in this report is segmented –
1) By Product: Consumable Accessories, Instruments
2) By Application: Blood Analysis, Urine Analysis, Microbial Cell Count, Cell Line Viability, Other Applications
3) By End User: Pharmaceuticals And Biotechnology Companies, Hospitals, Diagnostics Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Consumable Accessories: Cell Counting Reagents, Cell Counting Slides, Sample Tubes
2) By Instruments: Hemocytometers, Flow Cytometers, Automated Cell Counters (Optical Or Impedance-Based)
What Are The Prominent Trends In The Automated Cell Counter Market?
Major companies operating in the automated cell counter market are focusing on the integration of intelligence algorithms and machine learning, such as the AI automated cell culture system, to optimize and automate the process of cell growth and scalability in biological research and biomanufacturing. An AI-automated cell culture system is a technology that utilizes artificial intelligence to autonomously monitor, manage, and optimize cell growth and maintenance in laboratory settings. For instance, in October 2023, Molecular Devices LLC, a U.S.-based supplier of analytical systems, introduced the CellXpress.ai automated cell culture system, an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab. The hub incorporates cutting-edge technology designed to seamlessly oversee the entire cell journey. It boasts advanced machine learning-powered software that simplifies the navigation and supervision of complex cell culture processes, complete with pre-programmed protocols for generating both 2D and 3D models.
Analysis Of Key Players In Automated Cell Counter Market
Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd., Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc., Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.
View the full automated cell counter market report here:
What Are The Key Regional Trends In The Automated Cell Counter Market?
North America was the largest region in the automated cell counter market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell counter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment